• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JAMA Net . H5 Influenza Vaccines—Moving Forward Against Pandemic Threats

tetano

Editor, Senior Moderator
Concern about pandemic influenza looms as H5N1 viruses spread across species and continents. Although human cases remain limited, the current US outbreak raises alarming questions about preparedness for a pandemic. At this critical juncture, decisions about vaccine development, stockpiling, and deployment will shape the ability to respond to immediate and future pandemic risks.



North America is increasingly impacted by H5N1 influenza infections among poultry, cows, wild birds, and marine and terrestrial mammals, including at least 13 human infections related to animal contact,[SUP]1[/SUP] with genetic clade 2.3.4.4b viruses responsible for most recent cases. Although human illness has been mild so far, previous H5N1 viruses caused substantial mortality. Additionally, human-to-human transmission has not been reported in this outbreak and was uncommon with prior H5N1 strains, but surveillance is limited. The current extent of mammalian infection appears unprecedented, and a 2024 study suggested the virus may have acquired enhanced ability to bind mammalian airway receptors.[SUP]2[/SUP] The widespread presence of H5N1 among animals in proximity to humans, despite biocontainment efforts, increases risks for reassortment between human and animal viruses and selection of mutations that could enhance human transmission and threaten a pandemic.

https://jamanetwork.com/journals/jama/article-abstract/2823004
 
Back
Top Bottom